Physician profile
Ann Overy
NPI 1306020086
$944.71
in general payments reported to CMS, 2019-2025
18 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $10.98 · 2022: $42.14 · 2023: $334 · 2024: $240 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $164.32 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Ironshore Pharmaceuticals INC. | $138.43 | 2023-2024 | Jornay Pm |
| Pfizer INC. | $134.01 | 2019-2025 | |
| Sanofi Pasteur INC. | $99.44 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $75.65 | 2019-2024 | Vaxelis, Gardasil 9, Gardasil |
| Astrazeneca Pharmaceuticals LP | $47.03 | 2023 | Farxiga |
| Glaxosmithkline, LLC. | $45.27 | 2023-2025 | Shingrix, Bexsero, Arexvy |
| Janssen Pharmaceuticals, INC | $42.57 | 2019-2024 | Spravato |
| Exact Sciences Corporation | $29.36 | 2023-2024 | Cologuard Collection Kit |
| Philips North America LLC | $22.13 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.62 | 2019-2020 | |
| Dexcom, INC. | $21.54 | 2024 | Dexcom G6 Transmitter |
| Acadia Pharmaceuticals INC | $19.09 | 2023 | Daybue |
| Biofrontera INC. | $18.92 | 2019 | |
| Antares Pharma, INC. | $18.31 | 2023 | Nocdurna, Xyosted, Tlando |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.37 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.31 | 2023 | Xifaxan |
| Corium, LLC | $13.34 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Overy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.